Japanese encephalitis virus envelope and non-structural proteins — Drug Target

All drugs that target Japanese encephalitis virus envelope and non-structural proteins — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Inactivated viral vaccine

Phase 3 pipeline (1)

• C) primary immunizations with Ixiaro · Helsinki University Central Hospital · Inactivated viral vaccine · Immunology / Infectious Disease
  Ixiaro is an inactivated Japanese encephalitis virus vaccine that stimulates the immune system to produce antibodies and cellular immunity against Japanese encephalitis virus.